AGENT ORANGE-INDUCED Anaplastic Large-Cell Lymphoma (ALCL) with Cutaneous Involvement

Overview

Journal Clin Case Rep

Date 2021 May 3

PMID 33936698

Citations 1

Authors

Morgan Lorio

Brandon Lewis

John Hoy

Matthew Yeager

Affiliations

Soon will be listed here.

Abstract

Anaplastic large-cell lymphoma (ALCL) is a CD30 + lymphoproliferative disorder that may manifest with skin involvement. We present a rare case of Agent Orange-induced ALCL with cutaneous involvement of the hand, surgical excision, and follow-up treatment.

Citing Articles

AGENT ORANGE-INDUCED Anaplastic Large-Cell Lymphoma (ALCL) with Cutaneous Involvement.

Lorio M, Lewis B, Hoy J, Yeager M Clin Case Rep. 2021; 9(4):2373-2381.

PMID: 33936698 PMC: 8077270. DOI: 10.1002/ccr3.4041.

References

Kempf W, Pfaltz K, Vermeer M, Cozzio A, Ortiz-Romero P, Bagot M . EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma. Blood. 2011; 118(15):4024-35. PMC: 3204726. DOI: 10.1182/blood-2011-05-351346. View

Patrice S, Wiss K, Mulliken J . Pyogenic granuloma (lobular capillary hemangioma): a clinicopathologic study of 178 cases. Pediatr Dermatol. 1991; 8(4):267-76. DOI: 10.1111/j.1525-1470.1991.tb00931.x. View

Gascoyne R, Aoun P, Wu D, Chhanabhai M, Skinnider B, Greiner T . Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma. Blood. 1999; 93(11):3913-21. View

MACDONALD E . The epidemiology of skin cancer. J Invest Dermatol. 1959; 32(2, Part 2):379-82. View

Salehi Z, Mashayekhi F, Shahosseini F . Significance of eIF4E expression in skin squamous cell carcinoma. Cell Biol Int. 2007; 31(11):1400-4. DOI: 10.1016/j.cellbi.2007.06.006. View

Lorio M, Ziakas G, Masker K, Howell S, Lewis B . Use of artificial dermal substitute as a bridge in complex finger reconstruction. Wounds. 2015; 24(5):120-3. View

Alam M, Ratner D . Cutaneous squamous-cell carcinoma. N Engl J Med. 2001; 344(13):975-83. DOI: 10.1056/NEJM200103293441306. View

Truss L, Dobin S, Donner L . Deletion (21)(q21.2q22.12) as a sole clonal cytogenetic abnormality in a lobular capillary hemangioma of the nasal cavity. Cancer Genet Cytogenet. 2006; 170(1):69-70. DOI: 10.1016/j.cancergencyto.2006.04.016. View

McCaig L, Burt C . National Hospital Ambulatory Medical Care Survey: 2002 emergency department summary. Adv Data. 2004; (340):1-34. View

10.

Anderson M, Newmeyer 3rd W, KILGORE Jr E . Diagnosis and treatment of retained foreign bodies in the hand. Am J Surg. 1982; 144(1):63-7. DOI: 10.1016/0002-9610(82)90603-1. View

11.

Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T . Cancer statistics, 2008. CA Cancer J Clin. 2008; 58(2):71-96. DOI: 10.3322/CA.2007.0010. View

12.

Frumkin H . Agent Orange and cancer: an overview for clinicians. CA Cancer J Clin. 2003; 53(4):245-55. DOI: 10.3322/canjclin.53.4.245. View

13.

Lorio M, Lewis B, Hoy J, Yeager M . AGENT ORANGE-INDUCED Anaplastic Large-Cell Lymphoma (ALCL) with Cutaneous Involvement. Clin Case Rep. 2021; 9(4):2373-2381. PMC: 8077270. DOI: 10.1002/ccr3.4041. View

14.

English D, Armstrong B, Kricker A, Winter M, Heenan P, Randell P . Demographic characteristics, pigmentary and cutaneous risk factors for squamous cell carcinoma of the skin: a case-control study. Int J Cancer. 1998; 76(5):628-34. DOI: 10.1002/(sici)1097-0215(19980529)76:5<628::aid-ijc3>3.0.co;2-s. View

15.

Moskowitz A, Lunning M, Horwitz S . How I treat the peripheral T-cell lymphomas. Blood. 2014; 123(17):2636-44. PMC: 4507040. DOI: 10.1182/blood-2013-12-516245. View

16.

Yu J, Cheng K . Letter: Migration of broken sewing needle from left arm to heart. Chest. 1975; 67(5):626-7. DOI: 10.1378/chest.67.5.626. View

17.

McCaig L, Nawar E . National Hospital Ambulatory Medical Care Survey: 2004 emergency department summary. Adv Data. 2006; (372):1-29. View

18.

Lee J, Sinno H, Tahiri Y, Gilardino M . Treatment options for cutaneous pyogenic granulomas: a review. J Plast Reconstr Aesthet Surg. 2011; 64(9):1216-20. DOI: 10.1016/j.bjps.2010.12.021. View

19.

Bekkenk M, Geelen F, van Voorst Vader P, Heule F, Geerts M, van Vloten W . Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment. Blood. 2000; 95(12):3653-61. View

20.

Wilcox R . Optimising initial treatment for peripheral T-cell lymphoma: a tough nut to CHOP. Lancet Haematol. 2018; 5(5):e182-e183. DOI: 10.1016/S2352-3026(18)30047-4. View